Alinity m reagents and supplies
Ended Awarded Last action
- Contract number
- 36C25924N0069
- Awardee
-
Abbott Molecular Inc. UEI NK5QDVJBHMN7 Part of Abbott Laboratories
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $250,165
Award facts
- Contract value 9% obligated
-
- $250,165.34 Current, with exercised options
- $2,762,709.52 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Aurora, CO 80045, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$312,440 | |
| Funding Only Action | -$125,000 | |
| Original award | $687,605 |
About this award
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, received a Blanket Purchase Agreement (BPA) call order valued at $2.76 million from Veterans Integrated Service Network 19 for Alinity M reagents and supplies. The contract, awarded on December 1, 2023, with completion targeted for November 30, 2024, operates under the General Services Administration's In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedule and utilizes firm fixed pricing. The supplies will be delivered to the Aurora, Colorado facility and support molecular diagnostic testing capabilities across the VA healthcare system. This award carries no small business set-aside designation, consistent with Abbott Molecular's status as a large, established medical technology corporation.
This BPA call represents one of several task orders Abbott Molecular has received under its broader $3.2 million indefinite delivery vehicle with VISN 19, which has issued six orders ranging from $350,000 to $2.76 million since December 2021. Abbott Molecular's Alinity M platform supplies critical molecular diagnostic capabilities for infectious disease testing, including COVID-19, HIV, and hepatitis C screening across multiple Veterans Integrated Service Networks. The company's entrenched position within VA procurement infrastructure is evidenced by its multiple blanket purchase agreements exceeding $12 million across various VISNs, supporting the Veterans Health Administration's diagnostic testing infrastructure and ensuring consistent access to essential molecular diagnostic supplies for veteran care delivery.
Quick answers
Who was awarded contract 36C25924N0069?
36C25924N0069 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on December 1, 2023.
How much is contract 36C25924N0069 worth?
The government has obligated $250,165 on 36C25924N0069. Its potential value, with all options, is $2,762,710.
Is contract 36C25924N0069 an order under another contract?
Yes. 36C25924N0069 is a BPA call under V797D40222-36C25922A0005, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25924N0069 competed?
The extent of competition for 36C25924N0069 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award